Parasite persistence in the aetiology of Chagas disease.
about
Evasion and Immuno-Endocrine Regulation in Parasite Infection: Two Sides of the Same Coin in Chagas Disease?A critical review on Chagas disease chemotherapyThe Trypanosoma cruzi protease cruzain mediates immune evasionBenznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas DiseasePathogenesis of chagas' disease: parasite persistence and autoimmunityTrypanosoma cruzi mitochondrial maxicircles display species- and strain-specific variation and a conserved element in the non-coding regionCombining residual insecticide spraying campaigns with targeted detection and specific chemotherapy for Trypanosoma cruzi infection in children.The challenges of Chagas Disease-- grim outlook or glimmer of hope.HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.Chagas cardiomyopathy in the context of the chronic disease transition.Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.Epidemiological modeling of Trypanosoma cruzi: Low stercorarian transmission and failure of host adaptive immunity explain the frequency of mixed infections in humansRole of endothelin 1 in the pathogenesis of chronic chagasic heart disease.Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis.Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infectionChagas disease and the london declaration on neglected tropical diseases.Structural and immunological characterization of sulphatides: relevance of sulphate moieties in Trypanosoma cruzi glycoconjugates.Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cellsTrypanosoma cruzi in persons without serologic evidence of disease, ArgentinaHumoral immune response against P2β from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage.Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infectionIdentification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arraysA DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas diseaseCharacterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.Innate and acquired immunity in the pathogenesis of Chagas disease.Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.Chagas cardiomyopathy and ischemic stroke.Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry.Host metabolism regulates intracellular growth of Trypanosoma cruzi.Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine.An update on the management of Chagas cardiomyopathy.DNA Vaccines against Protozoan Parasites: Advances and ChallengesImplications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.Parasites and immunotherapy: with or against?Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease
P2860
Q26744672-B4F88F44-68E0-4F20-97B0-AE1EBB39180BQ28216601-15AD23B5-FC9B-46AE-A58A-21EB4FF352E6Q28476751-2F67AE04-D41C-45A1-81E5-801F0EDFCB6AQ28548342-925E437D-71D1-4A1E-97BE-17DFB41C2E69Q28742827-C530E5AB-08F3-4334-A16B-EA1BFA93393BQ33237291-DF578D5A-ECC2-4A53-911D-7552F4CEC508Q33312445-5B74E12E-5E04-4CCB-9434-EAD2E4CF33F9Q33312506-3FA48356-BD8A-4D44-B489-87B404D94BF9Q33375075-AA1DC0F2-9481-4030-916F-6817459BD985Q33587293-927BAE39-5F7C-4F44-B747-3AB1F0E6AB6AQ33631293-6BEF3782-F093-4921-B852-593B3C2039B3Q33714036-157D5601-D3C0-4C39-ACBD-BFCB75FB172DQ33769435-716FDF6C-7FE6-4CD1-BF3B-2513C9F9AF0AQ34016698-7800F01D-7B6A-405B-8113-9C2E19B401ABQ34058668-7D945C5E-76C2-4FCB-A0D3-3A19D2851578Q34069688-DEBB53C3-E489-4400-AE8C-F02A5C76D226Q34075123-D6EC1438-473A-473A-ADEF-91E504E68F26Q34131388-4BEB9B71-8080-4833-80B2-157DFAB01984Q34315066-B73C394A-78AF-4B67-8A33-80C1D9C1B869Q34318631-3F9EE791-0A3D-48B4-AC53-3D62CFB0FA6EQ34491767-C439F397-C83D-4843-8CB6-EF2DA67F1B2FQ34554966-F820DB6F-C67A-44C1-BEC9-4825A146703EQ34707808-036E15EF-CB7A-45B5-B1A0-20D5BDE3ACA5Q35035389-65805676-45B5-4DC1-A429-9F87A6BC6DCEQ35037072-8AE79AFC-9AEA-40E5-8DBA-3C294450D1D2Q35565140-47A0C2ED-2874-405E-907E-37683401C25DQ35739066-9F515F30-758E-458D-930D-E229F9A5A481Q35994773-CBB420F7-FC2F-43E6-ADF6-1449B2C3AFE7Q36229272-09889EB4-CF6D-4F14-A7DB-99248467FF99Q36352043-2CF9BC7A-A497-4320-93B2-F01935EE4F43Q36385476-04BEFA88-B383-44AC-BEE1-C70F21132328Q36578029-27FD10E2-ABBD-4FBE-ACA8-AA412F4C424DQ36606779-342C3E48-7D84-4A30-9F7B-CBE10E8C5824Q36844914-B9B24DD3-FB80-48A0-A027-B4FA7A81335AQ36901969-ED0F1C57-B6E3-431F-B8C8-49AA4622A699Q36901974-CC23916C-2E6B-4A50-9D92-39BD50139BFDQ36915067-218F0DA3-B38F-415A-9F9E-68325A31156AQ36949822-403264B6-3EC0-4DA6-B689-84205257BEFFQ37053248-7B7983BF-7CF5-4711-B943-31C4352DDC76Q37116835-002CAC6E-B20C-47C0-B65D-98B8F0EF3F76
P2860
Parasite persistence in the aetiology of Chagas disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Parasite persistence in the aetiology of Chagas disease.
@ast
Parasite persistence in the aetiology of Chagas disease.
@en
Parasite persistence in the aetiology of Chagas disease.
@nl
type
label
Parasite persistence in the aetiology of Chagas disease.
@ast
Parasite persistence in the aetiology of Chagas disease.
@en
Parasite persistence in the aetiology of Chagas disease.
@nl
prefLabel
Parasite persistence in the aetiology of Chagas disease.
@ast
Parasite persistence in the aetiology of Chagas disease.
@en
Parasite persistence in the aetiology of Chagas disease.
@nl
P1476
Parasite persistence in the aetiology of Chagas disease.
@en
P2093
Tarleton RL
P304
P356
10.1016/S0020-7519(01)00158-8
P577
2001-05-01T00:00:00Z